Fortis Life Sciences provides products and services related to life sciences, including molecular reagents, immunoassays, and custom services for researchers and diagnostic manufacturers.

Fortis Life Sciences

Beckman Coulter Diagnostics provides products and services in the fields of clinical diagnostics, including chemistry, immunoassay, hematology, urinalysis, and microbiology. They focus on laboratory automation and informatics solutions.

Beckman Coulter Diagnostics

MBDA is a European defense systems company that specializes in the development of missile systems and services.

MBDA

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Metric
Company Name	Fortis Life Sciences	Beckman Coulter Diagnostics	MBDA	Qiagen N.V.
Symbol				QGEN
MSH ID	COM:FORTISLIFE	COM:BECKMANCOULTER	COM:MBDA-SYSTEMS	COM:QIAGEN
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services	Healthcare
Industry	Biotechnology	Diagnostic Equipment and Supplies	Defense	Medical - Diagnostics & Research
Country	US	US	FR	NL
Stage
Employee Count				5.90K
Website	fortislife.com	beckmancoulter.com	mbda-systems.com	qiagen.com
LinkedIn				qiagen
Founders

Metric
Market Cap			9.10B
Enterprise Value
Monthly Web Traffic	16.61K	386.71K
Web Traffic Growth	0.06	0.41
Valuation
Raised Capital

Metric
Revenue				1.97B
Revenue (LTM)
Revenue (NTM)
Gross Profit				1.22B
EBITDA				650.58M
Operating Income				445.25M
Net Income				341.30M
EPS				1.54
Diluted EPS				1.53
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.64
Operating Profit Margin				0.24
EBITDA Margin				0.33
Net Profit Margin				0.17
Return on Equity				0.09
Return on Assets				0.06
Return on Capital Employed				0.10

COM:FORTISLIFE

Fortis Life Sciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				29.01
P/B Ratio				2.61
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				5.38
EV Multiple				23.42

Metric
Days Sales Outstanding				61.02
Days Payables Outstanding				39.03
Days Inventory Outstanding				210.93
Operating Cycle				302.73
Cash Conversion Cycle				259.01
Asset Turnover				0.35

Metric
Operating Cash Flow				459.45M
Free Cash Flow				296.65M
Cash Flow to Debt				0.41
Operating Cash Flow/Sales				0.30
Free Cash Flow Yield				0.03

Metric
Cash & Equivalents				668.08M
Accounts Receivable				-55.12M
Inventory				398.38M
Goodwill				2.48B
Debt to Capitalization				0.29
Debt to Assets				0.25
Current Ratio				3.74
Quick Ratio				1.46

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.02
R&D to Revenue				0.10
SG&A to Revenue				0.06